(Q36757814)

16 August 2017

Pharmacodynamic interaction between RP 59500 and gram-positive bacteria infecting fibrin clots (English)

1 reference

16 August 2017

gram-positive bacteria

0 references

1 reference

A. Turcotte

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1444302

27 September 2022

M. G. Bergeron

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1444302

27 September 2022

language of work or name

English

0 references

publication date

1 October 1992

1 reference

full work available at URL

16 August 2017

5

1 reference

based on heuristic

inferred from page(s)

https://europepmc.org/articles/PMC245478

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1444302

https://europepmc.org/articles/PMC245478?pdf=render

27 September 2022

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1444302

Antimicrobial Agents and Chemotherapy

27 September 2022

published in

1 reference

16 August 2017

36

1 reference

16 August 2017

10

1 reference

16 August 2017

2211-2215

1 reference

Continuous vs. intermittent administration of antimicrobial agents: tissue penetration and efficacy in vivo

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245478

Influence of four modes of administration on penetration of aztreonam, cefuroxime, and ampicillin into interstitial fluid and fibrin clots and on in vivo efficacy against Haemophilus influenzae

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245478

The in-vitro activity, pharmacokinetics and tissue penetration of temafloxacin

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245478

Phenotypic and genotypic heterogeneity of glycopeptide resistance determinants in gram-positive bacteria

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245478

Ampicillin-resistant enterococcal species in an acute-care hospital

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245478

In vitro activity of RP 59500, a semisynthetic injectable pristinamycin, against staphylococci, streptococci, and enterococci

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245478

Emergence of vancomycin resistance in coagulase-negative staphylococci

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245478

Single oral dose pharmacokinetics of the two main components of pristinamycin in humans

28 June 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/1444302

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.36.10.2211

1 reference

16 August 2017

1 reference

PMC publication ID

245478

16 August 2017

1 reference

PMC publication ID

245478